| 1 |
33217013 | Evaluation of clinical and genetic factors in the population pharmacokinetics of carbamazepine. | 2021 Jun |
2 |
| 2 |
33671323 | Pharmacokinetics of the CYP3A4 and CYP2B6 Inducer Carbamazepine and Its Drug-Drug Interaction Potential: A Physiologically Based Pharmacokinetic Modeling Approach. | 2021 Feb 17 |
2 |
| 3 |
34373022 | Association of EPHX1 polymorphisms with plasma concentration of carbamazepine in epileptic patients: Systematic review and meta-analysis. | 2021 Sep |
6 |
| 4 |
34411648 | ABCB1 c.3435C > T and EPHX1 c.416A > G polymorphisms influence plasma carbamazepine concentration, metabolism, and pharmacoresistance in epileptic patients. | 2021 Dec 30 |
5 |
| 5 |
34612084 | Relevance of NR1I2 variants on carbamazepine therapy in Mexican Mestizos with epilepsy at a tertiary-care hospital. | 2021 Oct |
2 |
| 6 |
31164100 | Different EPHX1 methylation levels in promoter area between carbamazepine-resistant epilepsy group and carbamazepine-sensitive epilepsy group in Chinese population. | 2019 Jun 4 |
10 |
| 7 |
31650507 | Association between EPHX1 polymorphisms and carbamazepine metabolism in epilepsy: a meta-analysis. | 2019 Dec |
4 |
| 8 |
27276192 | Effects of EPHX1 and CYP3A4*22 genetic polymorphisms on carbamazepine metabolism and drug response among Tunisian epileptic patients. | 2016 Mar |
5 |
| 9 |
26314341 | Association between PK/PD-involved gene polymorphisms and carbamazepine-individualized therapy. | 2015 |
2 |
| 10 |
26555147 | Polymorphic Variants of SCN1A and EPHX1 Influence Plasma Carbamazepine Concentration, Metabolism and Pharmacoresistance in a Population of Kosovar Albanian Epileptic Patients. | 2015 |
3 |
| 11 |
24406279 | Pharmacogenetic potential biomarkers for carbamazepine adverse drug reactions and clinical response. | 2014 |
1 |
| 12 |
24817818 | Effects of EPHX1 and CYP3A4 polymorphisms on carbamazepine metabolism in epileptic patients. | 2014 |
4 |
| 13 |
24861996 | Association of ABCB1, CYP3A4, EPHX1, FAS, SCN1A, MICA, and BAG6 polymorphisms with the risk of carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in Chinese Han patients with epilepsy. | 2014 Aug |
6 |
| 14 |
25495409 | Effects of major transporter and metabolizing enzyme gene polymorphisms on carbamazepine metabolism in Chinese patients with epilepsy. | 2014 |
1 |
| 15 |
23252947 | Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy. | 2013 Jan |
2 |
| 16 |
24125961 | Effects of EPHX1, SCN1A and CYP3A4 genetic polymorphisms on plasma carbamazepine concentrations and pharmacoresistance in Chinese patients with epilepsy. | 2013 Dec |
2 |
| 17 |
22188362 | Association of polymorphisms in EPHX1, UGT2B7, ABCB1, ABCC2, SCN1A and SCN2A genes with carbamazepine therapy optimization. | 2012 Jan |
5 |
| 18 |
27713373 | Update on the Genetic Polymorphisms of Drug-Metabolizing Enzymes in Antiepileptic Drug Therapy. | 2010 Aug 20 |
1 |
| 19 |
19127076 | Carbamazepine hypersensitivity syndrome triggered by a human herpes virus reactivation in a genetically predisposed patient. | 2009 |
2 |
| 20 |
19364907 | The expression of human microsomal epoxide hydrolase is predominantly driven by a genetically polymorphic far upstream promoter. | 2009 Jul |
2 |
| 21 |
19620853 | Genetic variants in microsomal epoxide hydrolase influence carbamazepine dosing. | 2009 Jul-Aug |
4 |
| 22 |
17375979 | The role of pharmacogenetics in the metabolism of antiepileptic drugs: pharmacokinetic and therapeutic implications. | 2007 |
1 |
| 23 |
15692831 | Haplotype structures of EPHX1 and their effects on the metabolism of carbamazepine-10,11-epoxide in Japanese epileptic patients. | 2005 Mar |
1 |
| 24 |
9406998 | Tissue-specific expression and alternative splicing of human microsomal epoxide hydrolase. | 1997 Nov |
1 |
| 25 |
7503783 | Genetic analysis of microsomal epoxide hydrolase in patients with carbamazepine hypersensitivity. | 1995 Oct 26 |
2 |
| 26 |
7503784 | Kinetic parameters of lymphocyte microsomal epoxide hydrolase in carbamazepine hypersensitive patients. Assessment by radiometric HPLC. | 1995 Oct 26 |
2 |
| 27 |
7917777 | Lymphocyte microsomal epoxide hydrolase in patients on carbamazepine therapy. | 1994 Jun |
3 |